Document is current
Any future updates will be listed below
-
Authors
Widge, Alik S. https://orcid.org/0000-0001-8510-341X
Zhang, Fan
Gosai, Aishwarya
Papadimitrou, George
Wilson-Braun, Peter
Tsintou, Magdalini
Palanivelu, Senthil
Noecker, Angela M.
McIntyre, Cameron C.
O’Donnell, Lauren https://orcid.org/0000-0003-0197-7801
McLaughlin, Nicole C. R.
Greenberg, Benjamin D.
Makris, Nikolaos
Dougherty, Darin D. https://orcid.org/0000-0003-4691-4353
Rathi, Yogesh
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- License Information
-
More Information
Article History
Received: 21 April 2021
Revised: 11 August 2021
Accepted: 23 September 2021
First Online: 7 October 2021
Competing interests
: ASW and DDD have received research funding, device donations, and honoraria from Medtronic, which manufactured the DBS devices used in patients’ clinical care. Medtronic had no financial or technical role in this study. ASW and CCM have multiple patents and patent filings in the area of deep brain stimulation, including methods for optimizing/customizing stimulation parameters. CCM is a paid consultant for Boston Scientific Neuromodulation, receives royalties from Hologram Consultants, Neuros Medical, Qr8 Health, and is a shareholder in the following companies: Hologram Consultants, Surgical Information Sciences, CereGate, Autonomic Technologies, Cardionomic, and Enspire DBS. All other authors affirm no related financial interests.
